ArticleFrontiers in oncology2026

First-line penpulimab combined with anlotinib achieves complete response in an elderly patient with occult lung squamous cell carcinoma: a case report.

Xiaoling Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.